Ifp Advisors, Inc Glaukos Corp Transaction History

Ifp Advisors, Inc

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$82.27 - $103.29 $31,509 - $39,560	-383 Closed	0 $0
Q1 2025 May 05, 2025	BUY	$96.6 - $161.22 $9,080 - $15,154	94 Added 32.53%	383 $37,000
Q4 2024 Feb 04, 2025	BUY	$126.42 - $152.67 $36,535 - $44,121	289 New	289 $43,000
Q3 2021 Oct 06, 2021	SELL	$47.43 - $84.23 $8,252 - $14,656	-174 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$73.06 - $97.7 $170,887 - $228,520	-2,339 Reduced 93.08%	174 $15,000
Q1 2021 Apr 30, 2021	BUY	$70.43 - $97.42 $5,352 - $7,403	76 Added 3.12%	2,513 $210,000
Q4 2020 Jan 25, 2021	BUY	$48.9 - $75.26 $119,169 - $183,408	2,437 New	2,437 $184,000
Q3 2020 Oct 29, 2020	SELL	$37.23 - $50.97 $1,861 - $2,548	-50 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$58.58 - $83.91 $49,441 - $70,820	-844 Reduced 94.41%	50 $3,000
Q1 2019 May 15, 2019	BUY	$50.75 - $80.54 $45,370 - $72,002	894 New	894 $70,000
Q3 2018 Oct 25, 2018	SELL	$38.13 - $68.37 $381 - $683	-10 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$27.62 - $44.51 $1,104 - $1,780	-40 Reduced 80.0%	10 $0
Q4 2017 Jan 24, 2018	SELL	$24.5 - $36.01 $4,532 - $6,661	-185 Reduced 78.72%	50 $0
Q3 2017 Oct 30, 2017	BUY	$31.26 - $42.03 $1,094 - $1,471	35 Added 17.5%	235 $8,000
Q2 2017 Jun 03, 2019	SELL	N/A	-1,000 Reduced 83.33%	200 $8,000
Q1 2017 Jun 03, 2019	BUY	N/A	500 Added 71.43%	1,200 $62,000
Q4 2016 Jun 03, 2019	BUY	N/A	200 Added 40.0%	700 $24,000
Q2 2016 Jun 03, 2019	SELL	N/A	-394 Reduced 44.07%	500 $15,000
Q1 2016 Jun 03, 2019	BUY	N/A	894	894 $70,000

357

50.6M

252K

771K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.48B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.